Management of Acute Myeloid Leukemia in the Elderly

Studies evaluating chemotherapeutic treatment of acute myeloid leukemia in the elderly indicate that intensive therapy is required to induce durable responses. By providing full supportive measures, approximately 50% of patients go into complete remission and approximately 25% of responders will have durable complete remissions.